APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Marker

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cardiac Marker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173975080320 December 2025199 pages

Choose your research edition.

Industry ResearchCardiac Marker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Marker Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cardiac Marker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Marker Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Marker Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cardiac Marker market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiac Marker include BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, HyTest, Lee BioSolutions, Response Biomedical, Roche Diagnostics and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cardiac Marker market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiac Marker and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiac Marker sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiac Marker market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiac Marker Segment by Company

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

HyTest

Lee BioSolutions

Response Biomedical

Roche Diagnostics

Siemens Healthcare

Singulex

Sunfory

Thermo Scientific

Trinity Biotech

Abbott

Cardiac Marker Segment by Type

BNP & NT-proBNP

Troponin (cTnI and cTnT)

Myogloblin

Creatine kinase (CK) MB

Others (hs-CRP, D-Dimer, etc.)

Cardiac Marker Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Atherosclerosis

Congestive Heart Failure

Others

Cardiac Marker Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Marker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Marker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Marker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiac Marker market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cardiac Marker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cardiac Marker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cardiac Marker Industry Trends Table 2. Cardiac Marker Industry Drivers Table 3. Cardiac Marker Industry Opportunities and Challenges Table 4. Cardiac Marker Industry Restraints Table 5. Global Cardiac Marker Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cardiac Marker Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cardiac Marker Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cardiac Marker Sales Market Share by Manufacturers Table 9. Global Cardiac Marker Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cardiac Marker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cardiac Marker Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cardiac Marker Manufacturers, Product Type & Application Table 13. Global Cardiac Marker Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiac Marker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BNP & NT-proBNP Table 17. Major Manufacturers of Troponin (cTnI and cTnT) Table 18. Major Manufacturers of Myogloblin Table 19. Major Manufacturers of Creatine kinase (CK) MB Table 20. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.) Table 21. Global Cardiac Marker Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 23. Global Cardiac Marker Sales by Type (2027-2032) & (K Units) Table 24. Global Cardiac Marker Sales Market Share by Type (2021-2026) Table 25. Global Cardiac Marker Sales Market Share by Type (2027-2032) Table 26. Global Cardiac Marker Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Cardiac Marker Revenue by Type (2021-2026) & (K Units) Table 28. Global Cardiac Marker Revenue by Type (2027-2032) & (K Units) Table 29. Global Cardiac Marker Revenue Market Share by Type (2021-2026) Table 30. Global Cardiac Marker Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Myocardial Infarction Table 32. Major Manufacturers of Acute Coronary Syndrome Table 33. Major Manufacturers of Atherosclerosis Table 34. Major Manufacturers of Congestive Heart Failure Table 35. Major Manufacturers of Others Table 36. Global Cardiac Marker Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 38. Global Cardiac Marker Sales by Application (2027-2032) & (K Units) Table 39. Global Cardiac Marker Sales Market Share by Application (2021-2026) Table 40. Global Cardiac Marker Sales Market Share by Application (2027-2032) Table 41. Global Cardiac Marker Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cardiac Marker Revenue by Application (2021-2026) & (K Units) Table 43. Global Cardiac Marker Revenue by Application (2027-2032) & (K Units) Table 44. Global Cardiac Marker Revenue Market Share by Application (2021-2026) Table 45. Global Cardiac Marker Revenue Market Share by Application (2027-2032) Table 46. Global Cardiac Marker Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Cardiac Marker Sales by Region (2021-2026) & (K Units) Table 48. Global Cardiac Marker Sales Market Share by Region (2021-2026) Table 49. Global Cardiac Marker Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Cardiac Marker Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 53. North America Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 54. Europe Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 56. Europe Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 63. Global Cardiac Marker Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Cardiac Marker Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Cardiac Marker Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Cardiac Marker Revenue Market Share by Region (2021-2026) Table 67. Global Cardiac Marker Revenue Market Share by Region (2027-2032) Table 68. BG Medicine Company Information Table 69. BG Medicine Business Overview Table 70. BG Medicine Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BG Medicine Cardiac Marker Product Portfolio Table 72. BG Medicine Recent Development Table 73. Biomerieux Company Information Table 74. Biomerieux Business Overview Table 75. Biomerieux Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biomerieux Cardiac Marker Product Portfolio Table 77. Biomerieux Recent Development Table 78. Critical Diagnostics Company Information Table 79. Critical Diagnostics Business Overview Table 80. Critical Diagnostics Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Critical Diagnostics Cardiac Marker Product Portfolio Table 82. Critical Diagnostics Recent Development Table 83. DiaDexus Company Information Table 84. DiaDexus Business Overview Table 85. DiaDexus Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. DiaDexus Cardiac Marker Product Portfolio Table 87. DiaDexus Recent Development Table 88. HyTest Company Information Table 89. HyTest Business Overview Table 90. HyTest Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. HyTest Cardiac Marker Product Portfolio Table 92. HyTest Recent Development Table 93. Lee BioSolutions Company Information Table 94. Lee BioSolutions Business Overview Table 95. Lee BioSolutions Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lee BioSolutions Cardiac Marker Product Portfolio Table 97. Lee BioSolutions Recent Development Table 98. Response Biomedical Company Information Table 99. Response Biomedical Business Overview Table 100. Response Biomedical Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Response Biomedical Cardiac Marker Product Portfolio Table 102. Response Biomedical Recent Development Table 103. Roche Diagnostics Company Information Table 104. Roche Diagnostics Business Overview Table 105. Roche Diagnostics Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Roche Diagnostics Cardiac Marker Product Portfolio Table 107. Roche Diagnostics Recent Development Table 108. Siemens Healthcare Company Information Table 109. Siemens Healthcare Business Overview Table 110. Siemens Healthcare Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Siemens Healthcare Cardiac Marker Product Portfolio Table 112. Siemens Healthcare Recent Development Table 113. Singulex Company Information Table 114. Singulex Business Overview Table 115. Singulex Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Singulex Cardiac Marker Product Portfolio Table 117. Singulex Recent Development Table 118. Sunfory Company Information Table 119. Sunfory Business Overview Table 120. Sunfory Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sunfory Cardiac Marker Product Portfolio Table 122. Sunfory Recent Development Table 123. Thermo Scientific Company Information Table 124. Thermo Scientific Business Overview Table 125. Thermo Scientific Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Thermo Scientific Cardiac Marker Product Portfolio Table 127. Thermo Scientific Recent Development Table 128. Trinity Biotech Company Information Table 129. Trinity Biotech Business Overview Table 130. Trinity Biotech Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Trinity Biotech Cardiac Marker Product Portfolio Table 132. Trinity Biotech Recent Development Table 133. Abbott Company Information Table 134. Abbott Business Overview Table 135. Abbott Cardiac Marker Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Abbott Cardiac Marker Product Portfolio Table 137. Abbott Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Cardiac Marker Distributors List Table 141. Cardiac Marker Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Cardiac Marker Product Image Figure 2. Global Cardiac Marker Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Marker Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac Marker Sales (2021-2032) & (K Units) Figure 5. Global Cardiac Marker Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cardiac Marker Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BNP & NT-proBNP Image Figure 9. Troponin (cTnI and cTnT) Image Figure 10. Myogloblin Image Figure 11. Creatine kinase (CK) MB Image Figure 12. Others (hs-CRP, D-Dimer, etc.) Image Figure 13. Global Cardiac Marker Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cardiac Marker Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cardiac Marker Sales Market Share by Type (2021-2032) Figure 16. Global Cardiac Marker Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Cardiac Marker Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Cardiac Marker Revenue Market Share by Type (2021-2032) Figure 19. Myocardial Infarction Image Figure 20. Acute Coronary Syndrome Image Figure 21. Atherosclerosis Image Figure 22. Congestive Heart Failure Image Figure 23. Others Image Figure 24. Global Cardiac Marker Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Cardiac Marker Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Cardiac Marker Sales Market Share by Application (2021-2032) Figure 27. Global Cardiac Marker Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Cardiac Marker Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Cardiac Marker Revenue Market Share by Application (2021-2032) Figure 30. North America Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Cardiac Marker Sales Market Share by Country (2021-2032) Figure 32. U.S. Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Cardiac Marker Sales Market Share by Country (2021-2032) Figure 37. Germany Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Cardiac Marker Sales Market Share by Country (2021-2032) Figure 44. China Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Cardiac Marker Sales Market Share by Country (2021-2032) Figure 52. Brazil Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Cardiac Marker Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Cardiac Marker Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Cardiac Marker Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Cardiac Marker Revenue (2021-2032) & (US$ Million) Figure 63. North America Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Cardiac Marker Revenue (2021-2032) & (US$ Million) Figure 65. Europe Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Cardiac Marker Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Cardiac Marker Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Cardiac Marker Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Cardiac Marker Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BNP & NT-proBNP
  • Troponin (cTnI and cTnT)
  • Myogloblin
  • Creatine kinase (CK) MB
  • Others (hs-CRP, D-Dimer, etc.)
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Congestive Heart Failure
  • Others
Companies covered
  • BG Medicine
  • Biomerieux
  • Critical Diagnostics
  • DiaDexus
  • HyTest
  • Lee BioSolutions
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Singulex
  • Sunfory
  • Thermo Scientific
  • Trinity Biotech
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cardiac Marker Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cardiac Marker Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cardiac Marker Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cardiac Marker Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cardiac Marker Market Dynamics
  1. 2.1 Cardiac Marker Industry Trends
  2. 2.2 Cardiac Marker Industry Drivers
  3. 2.3 Cardiac Marker Industry Opportunities and Challenges
  4. 2.4 Cardiac Marker Industry Restraints
3 Cardiac Marker Market by Manufacturers
  1. 3.1 Global Cardiac Marker Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cardiac Marker Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cardiac Marker Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cardiac Marker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiac Marker Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cardiac Marker Manufacturers, Product Type & Application
  7. 3.7 Global Cardiac Marker Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiac Marker Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiac Marker Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiac Marker Tier 1, Tier 2, and Tier 3
4 Cardiac Marker Market by Type
  1. 4.1 Cardiac Marker Type Introduction
  2. 4.1.1 BNP & NT-proBNP
  3. 4.1.2 Troponin (cTnI and cTnT)
  4. 4.1.3 Myogloblin
  5. 4.1.4 Creatine kinase (CK) MB
  6. 4.1.5 Others (hs-CRP, D-Dimer, etc.)
  7. 4.2 Global Cardiac Marker Sales by Type
  8. 4.2.1 Global Cardiac Marker Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Cardiac Marker Sales by Type (2021-2032)
  10. 4.2.3 Global Cardiac Marker Sales Market Share by Type (2021-2032)
  11. 4.3 Global Cardiac Marker Revenue by Type
  12. 4.3.1 Global Cardiac Marker Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Cardiac Marker Revenue by Type (2021-2032)
  14. 4.3.3 Global Cardiac Marker Revenue Market Share by Type (2021-2032)
5 Cardiac Marker Market by Application
  1. 5.1 Cardiac Marker Application Introduction
  2. 5.1.1 Myocardial Infarction
  3. 5.1.2 Acute Coronary Syndrome
  4. 5.1.3 Atherosclerosis
  5. 5.1.4 Congestive Heart Failure
  6. 5.1.5 Others
  7. 5.2 Global Cardiac Marker Sales by Application
  8. 5.2.1 Global Cardiac Marker Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cardiac Marker Sales by Application (2021-2032)
  10. 5.2.3 Global Cardiac Marker Sales Market Share by Application (2021-2032)
  11. 5.3 Global Cardiac Marker Revenue by Application
  12. 5.3.1 Global Cardiac Marker Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cardiac Marker Revenue by Application (2021-2032)
  14. 5.3.3 Global Cardiac Marker Revenue Market Share by Application (2021-2032)
6 Global Cardiac Marker Sales by Region
  1. 6.1 Global Cardiac Marker Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiac Marker Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiac Marker Sales by Region (2021-2026)
  4. 6.2.2 Global Cardiac Marker Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cardiac Marker Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cardiac Marker Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cardiac Marker Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cardiac Marker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cardiac Marker Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cardiac Marker Revenue by Region
  1. 7.1 Global Cardiac Marker Revenue by Region
  2. 7.1.1 Global Cardiac Marker Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cardiac Marker Revenue by Region (2021-2026)
  4. 7.1.3 Global Cardiac Marker Revenue by Region (2027-2032)
  5. 7.1.4 Global Cardiac Marker Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cardiac Marker Revenue (2021-2032)
  8. 7.2.2 North America Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cardiac Marker Revenue (2021-2032)
  11. 7.3.2 Europe Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cardiac Marker Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cardiac Marker Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cardiac Marker Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BG Medicine
  2. 8.1.1 BG Medicine Company Information
  3. 8.1.2 BG Medicine Business Overview
  4. 8.1.3 BG Medicine Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BG Medicine Cardiac Marker Product Portfolio
  6. 8.1.5 BG Medicine Recent Developments
  7. 8.2 Biomerieux
  8. 8.2.1 Biomerieux Company Information
  9. 8.2.2 Biomerieux Business Overview
  10. 8.2.3 Biomerieux Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biomerieux Cardiac Marker Product Portfolio
  12. 8.2.5 Biomerieux Recent Developments
  13. 8.3 Critical Diagnostics
  14. 8.3.1 Critical Diagnostics Company Information
  15. 8.3.2 Critical Diagnostics Business Overview
  16. 8.3.3 Critical Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Critical Diagnostics Cardiac Marker Product Portfolio
  18. 8.3.5 Critical Diagnostics Recent Developments
  19. 8.4 DiaDexus
  20. 8.4.1 DiaDexus Company Information
  21. 8.4.2 DiaDexus Business Overview
  22. 8.4.3 DiaDexus Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DiaDexus Cardiac Marker Product Portfolio
  24. 8.4.5 DiaDexus Recent Developments
  25. 8.5 HyTest
  26. 8.5.1 HyTest Company Information
  27. 8.5.2 HyTest Business Overview
  28. 8.5.3 HyTest Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HyTest Cardiac Marker Product Portfolio
  30. 8.5.5 HyTest Recent Developments
  31. 8.6 Lee BioSolutions
  32. 8.6.1 Lee BioSolutions Company Information
  33. 8.6.2 Lee BioSolutions Business Overview
  34. 8.6.3 Lee BioSolutions Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lee BioSolutions Cardiac Marker Product Portfolio
  36. 8.6.5 Lee BioSolutions Recent Developments
  37. 8.7 Response Biomedical
  38. 8.7.1 Response Biomedical Company Information
  39. 8.7.2 Response Biomedical Business Overview
  40. 8.7.3 Response Biomedical Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Response Biomedical Cardiac Marker Product Portfolio
  42. 8.7.5 Response Biomedical Recent Developments
  43. 8.8 Roche Diagnostics
  44. 8.8.1 Roche Diagnostics Company Information
  45. 8.8.2 Roche Diagnostics Business Overview
  46. 8.8.3 Roche Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Diagnostics Cardiac Marker Product Portfolio
  48. 8.8.5 Roche Diagnostics Recent Developments
  49. 8.9 Siemens Healthcare
  50. 8.9.1 Siemens Healthcare Company Information
  51. 8.9.2 Siemens Healthcare Business Overview
  52. 8.9.3 Siemens Healthcare Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
  54. 8.9.5 Siemens Healthcare Recent Developments
  55. 8.10 Singulex
  56. 8.10.1 Singulex Company Information
  57. 8.10.2 Singulex Business Overview
  58. 8.10.3 Singulex Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Singulex Cardiac Marker Product Portfolio
  60. 8.10.5 Singulex Recent Developments
  61. 8.11 Sunfory
  62. 8.11.1 Sunfory Company Information
  63. 8.11.2 Sunfory Business Overview
  64. 8.11.3 Sunfory Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sunfory Cardiac Marker Product Portfolio
  66. 8.11.5 Sunfory Recent Developments
  67. 8.12 Thermo Scientific
  68. 8.12.1 Thermo Scientific Company Information
  69. 8.12.2 Thermo Scientific Business Overview
  70. 8.12.3 Thermo Scientific Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Scientific Cardiac Marker Product Portfolio
  72. 8.12.5 Thermo Scientific Recent Developments
  73. 8.13 Trinity Biotech
  74. 8.13.1 Trinity Biotech Company Information
  75. 8.13.2 Trinity Biotech Business Overview
  76. 8.13.3 Trinity Biotech Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Trinity Biotech Cardiac Marker Product Portfolio
  78. 8.13.5 Trinity Biotech Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott Cardiac Marker Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Abbott Cardiac Marker Product Portfolio
  84. 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiac Marker Value Chain Analysis
  2. 9.1.1 Cardiac Marker Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiac Marker Production Mode & Process
  6. 9.2 Cardiac Marker Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiac Marker Distributors
  9. 9.2.3 Cardiac Marker Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst